CINCOR PHARMA
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor’s lead program is CIN-107, a novel aldosterone synthase inhibitor.
CINCOR PHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.cincor.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
418 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Microsoft Exchange Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - CinCor Pharma
Sofinnova Investments
Sofinnova Investments investment in Series B - CinCor Pharma
RTW Investments LLC
RTW Investments LLC investment in Series B - CinCor Pharma
General Atlantic
General Atlantic investment in Series B - CinCor Pharma
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - CinCor Pharma
BVF Partners
BVF Partners investment in Series B - CinCor Pharma
Omega Funds
Omega Funds investment in Series B - CinCor Pharma
Rock Springs Capital
Rock Springs Capital investment in Series B - CinCor Pharma
Perceptive Advisors
Perceptive Advisors investment in Series B - CinCor Pharma
Adage Capital Management
Adage Capital Management investment in Series B - CinCor Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-19 | CinCor Pharma Appoints Mason Freeman, M.D., as Executive VP, Clinical Development |
Official Site Inspections
http://www.cincor.com Semrush global rank: 2.86 M Semrush visits lastest month: 5.66 K
- Host name: ec2-98-83-184-133.compute-1.amazonaws.com
- IP address: 98.83.184.133
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
